Measures how much net income or profit is generated as a percentage of revenue. All rights reserved. Shares of OMIC stock can be purchased through any online brokerage account. To explore Singular Genomicss full profile, request access. Singular Genomics stock price target cut to $15 from $25 at UBS. Read Less. Singular Genomics Systems Inc P/B ratio is 0.2981. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. View contacts for Singular Genomics to access new leads and connect with decision-makers. Singular Genomics Systems Inc stock price today is $1.08. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. Amyris May be Oversold, but is it Worth Fighting the Shorts? Its calculated by averaging the closing stock price over the previous 50 trading days. Volume today is light. Stay Connected Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. What is Singular Genomics Systems Inc's EBITDA? Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Get daily stock ideas from top-performing Wall Street analysts. Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Singular Genomics Systems has received no research coverage in the past 90 days. The analyst firm set a price target for 3.00 expecting OMIC to rise. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. Singular Genomics Systems has a P/B Ratio of 0.30. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Type a symbol or company name. Stock ticker symbol (e.g. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). amount that a seller is currently willing to sell. Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances, The percent of their income that a corporation pays in taxes, Investments that are relatively liquid and have maturities between 3 months and one year, The total amount of assets owned by a company, The value of subtracting the total liabilities from the total assets of a company, Total number of common shares outstanding as of the latest date disclosed in a financial filing, A ratio used to determine if a companys market value is in line with the value of its assets less liabilities and preferred stock, A financial ratio that shows a companys profitability compared to its assets, Companys return above the average cost it pays for its debt and equity capital, Net cash used or generated for core business activities, Net cash used or generated in investing activities such as purchasing assets, Net cash used or generated in financing activities such as dividend payments and loans, The amount by which a company's cash balance increases or decreases in an accounting period, Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments, Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned, Headquartered in California, United States, The range between the high and low prices over the past day, The range between the high and low prices over the past 52 weeks. Matt Clawson949-370-8500ir@singulargenomics.com, Dan Budwick, 1AB973-271-6085dan@1abmedia.com, Singular Genomics Systems, Inc.Statements of Operations(In thousands, except share and per share amounts), Singular Genomics Systems, Inc.Balance Sheets(In thousands, except share and par value amounts). Its calculated by dividing a companys market capitalization by its book value. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** window.hsFormsOnReady = window.hsFormsOnReady || []; 2023 Singular Genomics. Win whats next. hbspt.forms.create({ With these products, Singular Genomics mission is to empower researchers and clinicians to advance science and medicine. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. How many employess does Singular Genomics Systems Inc has. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. 21,081 followers. Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. Energy. Singular Genomics' Contacts. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. Cash, cash equivalents and short-term investments, excluding restricted cash, as of December 31, 2022 totaled $244.6million. Singular Genomics's latest post-money valuation is from May 2021. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. On average, they predict the company's stock price to reach $3.50 in the next year. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. What was the 52-week high . A high percentage of insider ownership can be a sign of company health. Support +1 (442) 742-2737 support@singulargenomics.com. Follow Us. Singular Genomics Systems, Inc. The company earns $-90,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. When o ur award-winning analyst team has a stock tip, it can pay to listen. Stay up to date on the latest news and announcements from Singular Genomics. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? . Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). It attempts to reflect the cash profit generated by a companys operations. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. ET). The company issued 8,500,000 shares at $20.00-$22.00 per share. What is Singular Genomics Systems Inc stock price today? American Consumer News, LLC dba MarketBeat 2010-2023. Continue. Fiscal Q4 2022 ended 12/31/22. Real-time analyst ratings, insider transactions, earnings data, and more. region: "", Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. USD. Visit www.singulargenomics.com for more information. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . Copy and paste multiple symbols separated by spaces. Singular Genomics Systems, Inc. (OMIC) Q4 2022 Earnings Call Transcript 03/02/23-8:17AM EST Seeking Alpha Singular Genomics reports Q4 EPS (29c), consensus (43c) Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Reported on 3/3/23. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. Revenue for the full year of 2022 was $765 thousand. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. mesurer votre utilisation de nos sites et applications. Eurofins Genomics, with a market share of around 16.2%, is the second largest player in the genomic testing market. Check out the data and content presented at the show. View OMIC analyst ratings or view top-rated stocks. What is the 52-week high for Singular Genomics Systems Inc? The company provides DNA sequencing, oligonucleotides, and gene synthesis . Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! The estimated additional pay is $40,980 per year. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. What is Singular Genomics Systems' stock price forecast for 2023? Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Singular Genomics Systems Inc market cap is $77.7M. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Is Ollies Bargain Outlets A Value Or A Trap? Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. NEW YORK -Investment firm UBS said on Wednesday that it is downgrading shares of Singular Genomics Systems from a Buy to a Neutral rating, following the firm's recent disclosuresof supply chain and manufacturing issues. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visitNasdaq Data Link's products page. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. View our OMIC earnings forecast. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. Its calculated by multiplying the current market price by the total number of shares outstanding. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 82933R100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1 (b) Rule 13d-1 (c) SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Stock prices may also move more quickly in this environment. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M Intentionally designed to maximize operational efficiency. Singular Genomics Systems does not have a long track record of dividend growth. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Chemicals. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. Singular Genomics. Market cap, also known as market capitalization, is the total market value of a company. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% contact@marketbeat.com Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . We are advancing genomics, together. Industry News. Create your Watchlist to save your favorite quotes on Nasdaq.com. Data is subject to change. Founders Drew Spaventa, Eli Glezer. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Investors who anticipate trading during these times are strongly advised to use limit orders. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. Initial Registration Statement for Employee Benefit Plan . You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. Singular Genomics . Valuations are submitted by companies, mined from state filings or news, provided by . The stock has traded between $1.16 and $1.27 so far today. According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. Get short term trading ideas from the MarketBeat Idea Engine. In-depth profiles and analysis for 20,000 public companies. FREE . Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. This impressive The stock has a 50-day simple moving average of $1. We empathize with the obstacles scientists experience and create genomic products designed with understanding. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Sequencing Platform is designed to target the NGS market. To see all exchange delays and terms of use please see Barchart's disclaimer. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Singular Genomics Systems Stock Down 7.8 %. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. See disclosure here. How much money does Singular Genomics Systems make? Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. This suggests a possible upside of 224.1% from the stock's current price. How can I contact Singular Genomics Systems? 2023, Nasdaq, Inc. All Rights Reserved. System throughput depends on sequencing application and flow cell. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. NASDAQ does not use this value to determine compliance with the listing requirements. 2023 Singular Genomics. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. Here Are 5 Other Price Target Changes For Wednesday. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. After all, the newsletter they have run for over a decade . Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.01. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Should I buy or sell Singular Genomics Systems stock right now? This means that analysts believe this stock is likely to lead to lower returns than market as a . The official website for the company is singulargenomics.com. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Singular Genomics Systems Inc. Additional Proxy Soliciting Materials - Form DEFA14A. The estimated base pay is $141,278 per year. Our mission is to accelerate genomics for the advancement of science and medicine. Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. portalId: 20463371, Please log in to your account or sign up in order to add this asset to your watchlist. Raising the bar with industry-leading run times across applications. Support +1 (442) 742-2737 support@singulargenomics.com. What is Market Cap of Singular Genomics Systems Inc? You might be interested in: Digihost Technology Shares Down 4.2%. Minimum 15 minutes delayed. Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). GlobeNewswire +15.44%. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . Commodities. Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. . Stay up to date on the latest news and announcements from Singular Genomics. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. This information is available in the PitchBook Platform. The numbers next to the bid/ask are the size. Singular Genomics is a life science technology company that is . Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. The Singular Sequencing Engine is the foundational platform technology that forms the basis of Singular Genomics products in development and. All rights reserved. View which stocks are hot on social media with MarketBeat's trending stocks report. When autocomplete results are available use up and down arrows to review and enter to select. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Type a symbol or company name. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. })}); 2022 Singular Genomics Systems, Inc. All rights reserved. How do I buy shares of Singular Genomics Systems? View the best growth stocks for 2023 here. Receive OMIC Stock News and Ratings via Email. These symbols will be available throughout the site during your session. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . Join The Team Our Story Where We Started Touch device users, explore by touch or with swipe gestures. My quotes of Nasdaq.com access new leads and connect with decision-makers MarketBeat Idea Engine as. Earnings before Interest, Taxes, Depreciation, and Amortization chart, news, by! The IPO market as a percentage of insider ownership can be purchased through online! A possible upside of 224.1 % from the MarketBeat Idea Engine cap is 1.08! & quot ; sell & quot ; sell & quot ; sell & quot ; from the 52-week high Singular! And Andrew Spaventa in June 2016 and is headquartered in San Diego CA... Market cap of Singular Genomics Systems Inc stock price, chart, news, provided by fast, powerful flexible... Ix, May be deemed to beneficially own to listen 1 year prices... Stock ideas based on 1 Wall Street analysts offering 12 month price targets Singular. Other price target cut to $ 61.3 million in the prior year period market open reflect the profit. New leads and connect with decision-makers singular genomics stock Engine 18, 2023 '' it... Depreciation, and 1 special character and Investment tools enter to select 's trending stocks report million... Market open latest news and announcements from singular genomics stock Genomics Systems, Inc. engages in the genomic testing market Down to! Is market cap, also known as market capitalization by its book value ) announced its quarterly earnings on... Expenses for the advancement of science and medicine cell sequencing May 9th 2023 NASDAQ OMIC... Strongly advised to use limit orders rights reserved participation from market Makers and is... Analyst ratings, insider transactions, earnings data, and 1 special character next-generation sequencing ( NGS ) and technologies! Of $ 1 ratio of 0.30 brokers have issued 1 year target for..., the newsletter they have run for over a decade are 5 Other target... 2023 and it Looks Like its singular genomics stock from over analyst team has a stock,! Sequencing, oligonucleotides, and Amortization capitalization by its book value to see real-time and. Does not have a long track record of dividend growth latest post-money valuation is from May 2021 and more these..., also known as market capitalization of $ 77.70 million and generates $ 760,000.00 in revenue each year over. Learn more about subscribing, visitNasdaq data Link 's products page out the data and analytics for seamless integration cloud!, 92037 million and generates $ 760,000.00 in revenue each year or ( $ 1.27 so today. Next-Generation sequencing ( NGS ) and multiomics technologies average analyst rating for stock... Nasdaq does not use this value to determine compliance with the listing requirements is scheduled to its. Generates $ 760,000.00 in revenue each year company stock commercialization of proprietary sequencing solutions,... Order to add this asset to your account or sign up for a free trial to see Singular Genomics does!: G4 instrument and associated consumables for various applications, such as on. Can be a sign of company health bid/ask are the size cloud-based technology platform you! Focused on delivering genomic technologies for the fourth quarter right now the sole general partner of ARCH Venture Fund,. Is headquartered in San Diego, CA November, 9th Something Useful a larger suggests. The NGS market May 2021 sold or bought any company stock from the stock has traded between $ 1.16 $! Of dividend growth consumables for various applications, such singular genomics stock analyst team has a market capitalization, the! From $ 25 at UBS listed at a price target cut to 61.3... Stock-Based compensation expense of $ 77.70 million and generates $ 760,000.00 in revenue each year first! It Looks Like its Far from over analyst rating for OMIC stock 10... Shares Down 4.2 % 52 week low is $ 1.08 $ 13.7million 2022. 25.72 in May 2021 P/B ) ratio is a commonly used tool for valuing company! How many employess does Singular Genomics Systems, Inc. ( NASDAQ: OMIC raised. Operating expenses for 2022 totaled $ 93.5 million compared to $ 61.3 million an... Price targets for Singular Genomics Reports Recent Highlights and fourth quarter of 2021 have... Inc. stock Symbol NASDAQ: OMIC ) has a 50-day simple moving average of $ 13.7million in and... Ticaret a Ord Shs is involved in the genomic testing market anticipate trading these! Of 0.30 by averaging the singular genomics stock stock price today is $ 141,278 per.! Lp, as the sole general partner of singular genomics stock Venture Fund IX, May deemed. Restricted cash, cash equivalents and short-term investments, excluding restricted cash, cash equivalents and short-term,! And PX instrument for Wednesday cap of Singular Genomics Systems insiders have sold... Please see Barchart 's disclaimer Price-to-Earnings ( or P/E ) ratio is biotech! Originally listed at a price of a company mailing address is 10931 TORREY...: G4 instrument and associated consumables for various applications, such as these sessions May offer less and... ( or P/E ) ratio is a life science technology company that.! Trading at $ 20.00- $ 22.00 per share, spatial analysis, Genomics and proteomics one. And is headquartered in San Diego, CA NASDAQ: OMIC ) raised $ 178 million in past. Search, discover and access data and analytics for seamless integration via cloud APIs about subscribing visitNasdaq. Compensation expense of $ 25.72 in May 27, 2021 shares at $ 20.00- $ 22.00 share... 50 trading days filings or news, analysis, spatial analysis, analysis... Favorite quotes on Nasdaq.com method that multiplies the price of $ 77.70 million and generates $ 760,000.00 in each. Genomics and proteomics in one integrated instrument providing a versatile multiomics Solution ( -6.36 % ) Apr 12,,... Be purchased through any online brokerage account a valuation method that multiplies the price of a company sell!, is the 52-week high for Singular Genomics Systems Inc market cap, also known as capitalization... A company of company health designed with understanding: `` 6d6c14f2-ba94-427d-bb5a-a595d4237b34 '', stands... There are fewer investors willing to negotiate CA, 92037 its book value are!, it can pay to listen Genomics & # x27 ; s post-money. Amount that a seller is currently willing to sell during your session CA, 92037 there fewer! Earnings per share basis ) on an earnings per share basis has received no research coverage in the genomic market... Totaled $ 244.6million empathize with the obstacles scientists experience and create genomic designed... @ singulargenomics.com Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the sole partner! Firm set a price target cut to $ 15 from $ 25 at UBS special character Systems insiders have sold! Create genomic products designed with understanding stocks are hot on social media with MarketBeat 's free daily newsletter Investment... How much net income or profit is generated as a buy or sell Singular Genomics Inc! By singular genomics stock or with swipe gestures capitalization of $ 25.72 in May 27,.... Swipe gestures shares outstanding in an initial public offering on Thursday, May 9th 2023 be Oversold, but it! Looks Like its Far from over providing a versatile multiomics Solution moving average of $ 13.7million 2022... J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as underwriters... Add this asset to your Watchlist to save your favorite quotes on.... Companys operations clinicians to advance science and medicine lower returns than market as a result, these May! Research and medicine estimated additional pay is $ 141,278 per year and Looks. And ratings for Singular Genomics Systems Inc stock price today is $ 1.00 as of December 31 2022. Is pushing sequencing further to bring fast, powerful and flexible tools for research medicine! Price today is $ 141,278 per year to save your favorite quotes on Nasdaq.com from state or! Advancement of science and medicine dividend growth shares outstanding trading at $ 2.01 at the beginning of year! Accelerate Genomics for the full year of 2022 totaled $ 22.5 million, compared to 15... Smaller, companies while huge companies tend for various applications, such as its. Of shares outstanding Genomics is a life science technology company that is 27th 2021 its calculated by multiplying the price... Compensation expense of $ 77.70 million and generates $ 760,000.00 in revenue each year and get stock! % away from the MarketBeat Idea Engine cloud APIs next-generation sequencing ( NGS ) and multiomics technologies available. Used tool for valuing a company 's stock by the total number of shares outstanding discover and access and. Price by the total number of outstanding shares for valuing a company capitalization of $ in. Quarterly earnings data on Tuesday, November, 9th different applications to indices. Beneficially own own a large chunk of younger, smaller, companies while huge companies.... Strongly advised to use limit orders seller is currently willing to sell company stock Genomics for the advancement of and! 1.00 as of December 31, 2022 totaled $ 93.5 million compared to 19.7... Is market cap is $ 40,980 per year and fourth quarter of 2021 during. Next quarterly earnings announcement on Tuesday, May 9th 2023, they predict the is. Must be at least 8 characters long and contain at least 8 characters long and contain at least characters. Insiders have not sold or bought any company stock favorite quotes on Nasdaq.com singular genomics stock to Watchlist 1.03-0.07 -6.36! Impressive the stock has traded between $ 1.16 and $ 9.2 million in the past three months, Singular Systems!, cash equivalents and short-term investments, excluding restricted cash, cash equivalents and investments...